Claudio Umberto Köser

26PUBLICATIONS
68CO-AUTHORS
Medical infection agents (incl. prions)Medical bacteriologyMedical mycologyBacteriologyMicrobial genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Sep 22, 2025
In vitro exposure to clofazimine can select for delamanid and pretomanid resistance in Mycobacterium tuberculosis.

Praharshinie Rupasinghe, Nabila Ismail, Wim Mulders

|Aug 14, 2025
Quality control and considering systematic MIC shifts are key when evaluating the role of mmpR5 (Rv0678) frameshifts in bedaquiline resistance.

Thomas Schön, Paolo Miotto, Varvara K Kozyreva

|Apr 22, 2025
The ahpC c-54t compensatory mutation is not always a valid surrogate for isoniazid resistance in Mycobacterium tuberculosis.

Viktória Szél, Jody E Phelan, Sophia B Georghiou

|Apr 02, 2025
All parts of the WHO Mycobacterium tuberculosis mutation catalog need to be applied when evaluating its performance.

Sacha Laurent, Jody E Phelan, Leonid Chindelevitch

|Jul 11, 2024
A composite reference standard is needed for bedaquiline antimicrobial susceptibility testing for Mycobacterium tuberculosis complex.

Claudio U Köser, Paolo Miotto, Nabila Ismail

|Mar 14, 2024
The exceptions that prove the rule-a historical view of bedaquiline susceptibility.

Paolo Miotto, Daniela M Cirillo, Thomas Schön

Pageof 5